Dialyzer and Dialysis Market Segmentation:
Dialysis Type Segment Analysis
The hemodialysis segment in the dialyzer and dialysis market is the largest and is expected to reach 86% share by 2035. The development of new dialysis equipment, rising rates of hypertension, growing demand for home dialysis, and an increase in the prevalence of chronic illnesses (CKD) and end-stage renal disease (ESRD) are some of the major factors. Patients with renal disorders who are elderly are expected to significantly accelerate the segment growth. For instance, three men experience renal failure for every two women. Only 26,309 Americans, or around 1 in 4, were able to receive a kidney transplant in 2022 out of the over 90,000 people waiting for one. The development of new hemodialysis technologies and the rising use of hemodialysis are both driving the expansion of the segment in the market.
End-Users Segment Analysis
Dialyzer and dialysis market from the hospitals segment is expected to have a share of 78% by 2035. This is because the majority of patients with end-stage renal disease (ESRD) undergo dialysis in a hospital or dialysis facility. Numerous reasons, including the rising incidence of end-stage renal disease (ESRD), the expanding need for superior dialysis services, and the regulatory landscape, are driving the industry. The hospital industry is very concentrated, with a small number of very large companies controlling the majority of the market, including Fresenius Medical Care, Baxter International, and DaVita Healthcare. These businesses are well-known on a global scale and provide a variety of goods and services.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
Dialysis Type |
|
|
End-Users |
|
